PISTELLI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 149
AS - Asia 69
EU - Europa 69
SA - Sud America 9
AF - Africa 1
Totale 297
Nazione #
US - Stati Uniti d'America 147
SG - Singapore 44
IE - Irlanda 19
DE - Germania 16
RU - Federazione Russa 12
HK - Hong Kong 11
BR - Brasile 8
CN - Cina 8
UA - Ucraina 6
FI - Finlandia 5
JP - Giappone 3
SE - Svezia 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CA - Canada 1
MX - Messico 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 297
Città #
Chandler 30
Singapore 23
Dallas 19
Dublin 19
Jacksonville 18
Hong Kong 11
Munich 9
The Dalles 8
Ann Arbor 7
New York 7
Santa Clara 6
Ashburn 5
Boardman 4
Beijing 3
Bremen 3
Lawrence 3
Los Angeles 3
Princeton 3
Tokyo 3
Brno 2
Brussels 2
Columbus 2
Dearborn 2
Helsinki 2
Moscow 2
Turku 2
Warsaw 2
Wilmington 2
Al Ain City 1
Barretos 1
Bratsk 1
Brooklyn 1
Cabimas 1
Campo Grande 1
Charleston 1
Chicago 1
Conceição do Coité 1
Dhaka 1
Frankfurt am Main 1
Haiphong 1
Hangzhou 1
João Câmara 1
Lappeenranta 1
Lavras 1
Lithonia 1
London 1
Manchester 1
Mexico City 1
Orem 1
Osvaldo Cruz 1
Passo Fundo 1
Pretoria 1
Rio de Janeiro 1
Rostov-on-Don 1
Seattle 1
Stockholm 1
Taiyuan 1
Totale 231
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 119
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 94
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 87
Totale 300
Categoria #
all - tutte 1.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 3 1 3 0 4 0
2021/202214 0 1 0 0 3 0 0 2 2 0 1 5
2022/202368 3 8 0 12 7 8 0 3 26 0 0 1
2023/202418 2 1 0 0 1 7 0 0 0 1 0 6
2024/202585 1 2 4 5 13 4 7 5 21 4 12 7
2025/202678 10 12 17 15 16 8 0 0 0 0 0 0
Totale 300